Fox Chase patients may be eligible to receive third COVID-19 vaccine dose – Read More

MENU

Members

The Marvin and Concetta Greenberg Pancreatic Cancer Institute at Fox Chase Cancer Center is devoted to advancing pancreatic cancer therapies stemming from rational biological hypotheses, mechanistic investigation, human behavioral influence, community outreach, and early phase clinical trials. As a part of an NCI-designated Comprehensive Cancer, the Institute integrates both basic biological research, clinical medicine, populations science in this effort as well as substantial transdisciplinary research that bridges scientific areas.

At the core of this multidisciplinary Institute, our leaders strive to pull together these disparate sciences with a goal of spawning novel concepts with which to improve how pancreatic cancer patients are treated. The goals of the institute are to foster collaborative efforts amongst the disciplines and treat those with pancreatic cancer in the most advanced and comprehensive way possible. New discoveries are moved from the bench to bed side through the Institute’s pipeline.

Steering Committee

Igor Astaturov, MD, PhD

Co-Director, Marvin & Concetta Greenberg Pancreatic Cancer Institute
Associate Professor, Department of Hematology/Oncology

View Profile

Medical Oncology & Laboratory Research

Research focuses on cancer metabolism and signaling, with an emphasis on the role of sterol biosynthesis regulation in pancreatic cancer cell growth and survival

Edna (Eti) Cukierman, PhD

Co-Director, Marvin & Concetta Greenberg Pancreatic Cancer Institute
Professor
Co-Director, Immune Monitoring Facility
Chair, Institutional Biosafety Committee

View Profile

Laboratory Research

Research focuses on the tumor microenvironment, with an emphasis on cancer-associated fibroblastic cells, their extracellular matrix, function & how these partake in pancreatic cancer nutritional support, drug resistance, & immunosuppression

Sanjay S. Reddy, MD, FACS

Co-Director, Marvin & Concetta Greenberg Pancreatic Cancer Institute
Associate Professor, Department of Surgical Oncology
Associate Program Director, Complex General Surgical Oncology Fellowship
Collaborating Member, Molecular Therapeutics
Attending Surgeon

View Profile

Surgical Oncology

Practice focuses on vascular resectability and staging of pancreatic cancer as well as multimodality therapy for these patients

Efrat Dotan, MD

Chief, Division of Gastrointestinal Medical Oncology
Associate Professor, Department of Hematology/Oncology
Associate Director, Hematology/Oncology Fellowship Training Program

View Profile

Medical Oncology

Practice focuses on clinical trials testing novel therapies for pancreatic cancer patients and on care of older adults with cancer

Shannon Lynch, PhD, MPH

Assistant Professor, Cancer Prevention and Control

View Profile

Laboratory Research

Research focuses on intergration and analysis of complex, multilevel data resources in order to study how the neighborhood, or environment where a person lives, together with a person's behavior and biology, can impact cancer risk and cancer health disparities

Joshua E. Meyer, MD

Vice Chair, Translational Research, Department of Radiation Oncology
Associate Professor, Department of Radiation Oncology

View Profile

Radiation Oncology

Practice focuses on novel modalities of radiotherapy in pancreatic cancer with the goal of increasing surgically-resectable cohorts and improving patient outcomes

Program Manager

Benjamin A. Young, CCRP

Key Members

Kerry S. Campbell, PhD
Paul M. Campbell, PhD
Jason A. Castellanos, MD, MS
Carolyn Y. Fang, PhD
Michael J. Hall, MD, MS
Rishi Jain, MD, MS, DABOM
Clinical Faculty Members

Connect with Fox Chase